February 22, 2017
Pfizer cancels listing in the UK, U.S. FDA accept Inotuzamab submition for ALL in adults
Pfizer has decided to cancel listing of its stocks from the UK listing Authority List. The company said on Wednesday it also cancels trading on the main London Stock Exchange market.